Absci (ABSI) Net Cash Flow (2020 - 2026)
Absci (ABSI) reported Net Cash Flow of -$11.4 million for Q1 2026, down 292.67% on a YoY basis from $5.9 million in Q1 2025, and down 96.6% sequentially from -$5.8 million in Q4 2025.
Absci (ABSI) Net Cash Flow (2020 - 2026) Analysis & Trends
Absci (ABSI) has 7 years of Net Cash Flow data on file, last reported at -$11.4 million in Q1 2026.
- For the quarter ending Q1 2026, Net Cash Flow fell 292.67% year-over-year to -$11.4 million; the trailing twelve-month figure through Mar 2026 stood at -$54.4 million (down 346.86% YoY), and the FY2025 full-year result was -$37.1 million, down 18.07% from the prior year.
- Net Cash Flow slipped to -$11.4 million in Q1 2026, from -$5.8 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $49.7 million in Q2 2023 to a low of -$98.7 million in Q3 2022.
- A 5-year average of -$15.9 million and a median of -$11.4 million in 2026 frame the typical range for Net Cash Flow.
- Across the five-year window, Net Cash Flow soared 277.63% in 2023 and slumped 422.74% in 2025, its largest moves.
- Tracing ABSI's Net Cash Flow over 5 years: stood at -$47.4 million in 2022, then soared by 105.92% to $2.8 million in 2023, then gained by 9.43% to $3.1 million in 2024, then plunged by 289.0% to -$5.8 million in 2025, then slumped by 96.6% to -$11.4 million in 2026.
- Business Quant data shows ABSI's Net Cash Flow at -$11.4 million in Q1 2026, -$5.8 million in Q4 2025, and -$28.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - | -11.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.39 Mn |
| Mar 31, 2026 | -11.39 Mn |
| Dec 31, 2025 | -5.79 Mn |
| Dec 31, 2025 | -5.79 Mn |
| Sep 30, 2025 | -28.42 Mn |
| Sep 30, 2025 | -28.42 Mn |
| Jun 30, 2025 | -8.84 Mn |
| Jun 30, 2025 | -8.84 Mn |
| Mar 31, 2025 | 5.91 Mn |
| Mar 31, 2025 | 5.91 Mn |
| Dec 31, 2024 | 3.07 Mn |
| Dec 31, 2024 | 3.07 Mn |
| Sep 30, 2024 | -5.44 Mn |
| Sep 30, 2024 | -5.44 Mn |
| Jun 30, 2024 | -15.72 Mn |
| Jun 30, 2024 | -15.72 Mn |
| Mar 31, 2024 | -13.36 Mn |
| Mar 31, 2024 | -13.36 Mn |
| Dec 31, 2023 | 2.80 Mn |
| Dec 31, 2023 | 2.80 Mn |